Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ – Get Free Report)’s stock price was down 2.6% during mid-day trading on Tuesday . The company traded as low as $4.05 and last traded at $4.08. Approximately 266,534 shares changed hands during mid-day trading, an increase of 29% from the average daily volume of 205,918 shares. The stock had previously closed at $4.19.
Health Sciences Acquisitions Co. 2 Price Performance
The business has a 50-day simple moving average of $4.03 and a two-hundred day simple moving average of $4.18.
Health Sciences Acquisitions Co. 2 Company Profile
Health Sciences Acquisitions Co 2 is a Delaware‐incorporated special purpose acquisition company (SPAC) established to pursue a business combination with a company in the health sciences sector. Listed on the Nasdaq under the ticker HSAQ, the firm completed an initial public offering in early 2021, raising capital through the sale of units comprised of common stock and warrants.
As a blank‐check vehicle, Health Sciences Acquisitions Co 2 does not engage in commercial operations; rather, it focuses exclusively on identifying and combining with a private company operating in biotechnology, pharmaceuticals, medical devices or related life sciences fields.
Read More
- Five stocks we like better than Health Sciences Acquisitions Co. 2
- Apple and Broadcom Forge a Decade-Long Silicon Fortress
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
Receive News & Ratings for Health Sciences Acquisitions Co. 2 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Sciences Acquisitions Co. 2 and related companies with MarketBeat.com's FREE daily email newsletter.
